Pharmaceutical, biotechnology and medical products companies
January 08, 2019

Ayasdi Named Accenture HealthTech Innovation Challenge Innovation Champion

SAN FRANCISCO; Jan. 8, 2019 – Ayasdi has been named the Accenture HealthTech Innovation Challenge Innovation Champion, competing with more than 1,100 companies for the title. The competition pairs leading-edge startups with prominent health and life sciences organizations to develop innovative technology solutions that improve the way people access and manage healthcare.
December 21, 2018

Four Finalists in US and Canada Selected for Accenture HealthTech Innovation Challenge

NEW YORK; Dec. 21, 2018 – Using conversational artificial intelligence to improve care management and leveraging patient experiences to incentivize patients in their own health journey are among the innovative solutions being developed by the four North America-based finalists selected for the Accenture HealthTech Innovation Challenge.
December 11, 2018

Pierre Fabre Turns to Accenture to Digitize Corporate and Manufacturing Functions with SAP® S/4HANA®

PARIS; Dec. 11, 2018 – Pierre Fabre has selected Accenture (NYSE: ACN) to build an intelligent information technology (IT) platform to support and improve the performance of a range of functions including finance, accounting, procurement, order management and manufacturing  essential to the company’s global operations. The program is part of one of the most significant and strategic transformation initiatives ever undertaken at the French multinational health and beauty care company.
November 26, 2018

Accenture Expands Platform for Drug Discovery and Innovation with Creation of Life Sciences Partner Ecosystem

NEW YORK and LAS VEGAS; Nov. 26, 2018 – Accenture (NYSE: ACN) has created an open partner ecosystem designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and, ultimately, improve patient outcomes.
September 21, 2018

Accenture Introduces Ella and Ethan, AI Bots to Improve a Patient’s Health and Care Using the Accenture Intelligent Patient Platform

NEW YORK; Sept. 21, 2018 – Accenture (NYSE: ACN) has enhanced the Accenture Intelligent Patient Platform with the addition of Ella and Ethan, two interactive virtual-assistant bots that use artificial intelligence (AI) to constantly learn and make intelligent recommendations for interactions between life sciences companies, patients, health care providers (HCPs) and caregivers. Designed to help improve a patient’s health and overall experience, the bots are part of Accenture’s Salesforce Fullforce Solutions powered by Salesforce Health Cloud and Einstein AI, as well as Amazon’s Alexa.  
September 17, 2018

Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research

NEW YORK; Sept. 17, 2018 – Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development.
August 21, 2018

Accenture Named a Leader for Third Consecutive Time in the IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment for Strategic Consulting

NEW YORK; Aug. 21, 2018 – Accenture (NYSE: ACN) is positioned for a third consecutive time as a Leader in the IDC MarketScape vendor assessment, covering strategic consulting across the life sciences research and development (R&D) industry.
July 30, 2018

Accenture Positioned as a Leader in an IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment on IT Outsourcing for Third Consecutive Time

NEW YORK; July 30, 2018 – For the third consecutive time, Accenture (NYSE: ACN) is positioned as a Leader in the IDC MarketScape vendor assessment covering IT outsourcing (ITO) across the life sciences research and development (R&D) industry. 
July 12, 2018

Accenture Named a Leader in Worldwide Life Sciences R&D BPO Services by IDC MarketScape for Third Consecutive Time

NEW YORK; July 12, 2018 – Accenture (NYSE: ACN) has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process outsourcing (BPO) across the life sciences research and development (R&D) industry. This is the third consecutive time Accenture Life Sciences has achieved this prestigious ranking.
July 02, 2018

Accenture Seeks Emerging Innovators and Disruptors for Third Annual Accenture HealthTech Innovation Challenge

NEW YORK; July 2, 2018 – Accenture (NYSE: ACN) has kicked off the application period for the third annual Accenture HealthTech Innovation Challenge, which seeks to improve the way people access and manage healthcare.